Journal of Medical Radiation Sciences (Dec 2021)

Improving efficiency in the radiation management of multiple brain metastases using a knowledge‐based planning solution for single‐isocentre volumetric modulated arc therapy (VMAT) technique

  • James O’Toole,
  • Maddison Picton,
  • Mario Perez,
  • Michael Back,
  • Dasantha Jayamanne,
  • Andrew Le,
  • Kenny Wu,
  • Chris Brown,
  • John Atyeo

DOI
https://doi.org/10.1002/jmrs.526
Journal volume & issue
Vol. 68, no. 4
pp. 364 – 370

Abstract

Read online

Abstract Introduction This study aimed to develop a single‐isocentre volumetric modulated arc therapy (si‐VMAT) technique for multiple brain metastases using knowledge‐based planning software, comparing it with a multiple‐isocentre stereotactic radiosurgery (mi‐SRS) planning approach. Methods Twenty‐six si‐VMAT plans were created and uploaded into RapidPlanTM (RP) to create a si‐VMAT model. Ten patients, with 2 to 6 metastases (mets), were planned with a si‐VMAT technique utilising RP, and a mi‐SRS technique on Brainlab iPlan. Paddick Conformity Index (PCI) was used to compare conformity. The volumes of the brain receiving 15Gy, 12Gy, 10Gy, 7.5Gy and 3Gy were also compared. Retrospective treatment times from the last eight patients treated were averaged for pre‐imaging and beam on time to calculate treatment times for both techniques. Results There was a significant difference in the PCI scores for the mi‐SRS plans (M = 0.667, SD = 0.114) and si‐VMAT plans (M = 0.728, SD = 0.088), with PCI values suggesting better prescription dose conformity with the si‐VMAT technique (P = 0.014). Percentage of total brain volume receiving low‐dose wash at four of the five different dose levels was significantly less (P < 0.05) with mi‐SRS. Average time to treat a single met with current mi‐SRS technique is 25.7 min, with each additional met requiring this same amount of time. The average time to treat 2–3 mets using si‐VMAT would be 25.3 min and 4+ metastases 33.5 min. Conclusion A knowledge‐based si‐VMAT approach was efficient in planning and treating multi metastases while achieving clinically acceptable dosimetry with respect to dose conformity and low‐dose fall off.

Keywords